Aurinia Pharmaceuticals Inc (AUPH)

Income Tax Expense

-$153.75M

TTM · Period ending: · USD

AUPH logo

AUPH Income Tax Expense

Latest reported-$153.75M
AUPH TTM Income Tax ($203.79K → -$153.75M)
High-resolution chart · PNG

AUPH income tax expense history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aurinia Pharmaceuticals Inc Income Tax Expense — Trailing twelve months (TTM) (USD)
Period endingIncome Tax Expense (USD)
-153,751,000
-164,480,000
-173,045,000
1,803,000
1,849,000
1,962,000
1,696,000
2,411,000
2,252,000
854,000
551,000
947,000
1,603,000
2,254,000
1,828,000
1,699,000
753,000
762,000
760,000
191,000
168,000
152,000
-94,000
-161,000
-121,000
-107,000
144,000
127,000
102,000
86,000
73,000
0
0
0
0
0
0
-1,276,000
-1,276,000
-6,123,000
-6,068,000
-4,792,000
-4,792,000
55,000
0
0
30,000
-3,826,232
-4,043,374
-3,998,704
-4,004,133
-163,736
53,407
9,720
22,233
4,066,391
4,097,434
4,095,418
4,056,277
-354,249
-381,416
-534,437
-2,229,456
-1,847,254
-1,851,130
-1,503,271
868,550
1,604,993
1,754,455
1,562,614
899,528
163,095
13,633
29,978
310,448
1,790,433
1,653,008
1,935,761
2,437,079
1,063,355
1,504,724
1,203,661
530,906
880,607
252,366
-60,425
-154,424
437,452
394,102
473,036
211,977
-5,390,917
-3,704,908
285,625
252,264
4,809,462
3,349,964
-556,396
-480,071
-629,150
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.